
Year in Review: The 8 Most Important Lab Compliance Stories of 2023
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.
What 2023 Q3 earnings from 30 key US lab companies indicate about the current state of the industry and outlook for 2024.
Recent cases involve Medicare’s 14-Day Rule, improper PHI disclosure to a media outlet, kickbacks, and COVID-19 fraud.
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.